Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mega Genomics Limited ( (HK:6667) ) has provided an update.
Mega Genomics Limited has scheduled a board meeting for 4 February 2026 to review and approve the group’s interim results for the six months ended 30 June 2025. At the meeting, directors will also consider the declaration and payment of an interim dividend, if any, alongside other corporate matters, signaling upcoming disclosure of the company’s mid-year financial performance and potential shareholder returns.
More about Mega Genomics Limited
Mega Genomics Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange (stock code: 6667). The group operates through a board structure comprising executive, non-executive and independent non-executive directors, reflecting standard governance practices for a listed corporation, though the announcement does not specify its particular industry or product focus.
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.61B
For detailed information about 6667 stock, go to TipRanks’ Stock Analysis page.